StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP – Free Report) from a hold rating to a sell rating in a report issued on Monday.
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a research report on Thursday, August 29th.
Check Out Our Latest Research Report on Edap Tms
Edap Tms Stock Up 2.5 %
Edap Tms (NASDAQ:EDAP – Get Free Report) last posted its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The firm had revenue of $16.97 million during the quarter, compared to analysts’ expectations of $17.16 million. Analysts predict that Edap Tms will post -0.6 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Edap Tms
Hedge funds have recently modified their holdings of the stock. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Edap Tms in the 3rd quarter valued at about $36,000. BNP Paribas Financial Markets lifted its stake in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares during the period. Virtu Financial LLC bought a new position in Edap Tms during the 1st quarter valued at $82,000. Orion Capital Management LLC raised its position in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares in the last quarter. Finally, Commonwealth Equity Services LLC lifted its stake in Edap Tms by 5.9% during the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after purchasing an additional 4,000 shares during the last quarter. 62.74% of the stock is owned by institutional investors and hedge funds.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Read More
- Five stocks we like better than Edap Tms
- What Do S&P 500 Stocks Tell Investors About the Market?
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Using the MarketBeat Dividend Tax Calculator
- Williams-Sonoma Stock: Buy It and Never Let It Go
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.